Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...
Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Magnetic rocks with iron oxide concentrations act as natural chroniclers of Earth's past continental movements. Using small ...
NASHVILLE, Tenn., March 19, 2026 (GLOBE NEWSWIRE) -- The Costigan Group at Compass rolls out a structured pre-acquisition screening framework for short-term rental investors, giving buyers a ...
Space Compass Corporation ("Space Compass") and SWISSto12 SA ("SWISSto12") announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press ...
Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results